Treatment with tigecycline of recurrent urosepsis caused by extended-spectrum-β-lactamase-producing Escherichia coli

被引：23

作者：

Krueger, Wolfgang A. ^{[1
]}

Kempf, Volkhard A. J. ^{[3
]}

Peiffer, Manou ^{[1
]}

Nagele, Udo ^{[2
]}

Unertl, Klaus E. ^{[1
]}

Schroeder, Torsten H. ^{[1
]}

机构：

[1] Tubingen Univ Hosp, Dept Anesthesiol & Intens Care Med, D-72076 Tubingen, Germany

[2] Tubingen Univ Hosp, Dept Urol, D-72076 Tubingen, Germany

[3] Tubingen Univ Hosp, Inst Med Microbiol & Hyg, D-72076 Tubingen, Germany

来源：

JOURNAL OF CLINICAL MICROBIOLOGY | 2008年 / 46卷 / 02期

关键词：

D O I：

10.1128/JCM.01340-07

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

A 25-year-old female was admitted to our intensive care unit with septic shock and multiorgan failure caused by extended-spectrum beta-lactamase-producing Escherichia coli originating from the right renal pelvis. A 16-day course of treatment with meropenem reversed the septic condition, but the infection recurred thereafter. The patient recovered fully after therapy was changed to tigecycline.

引用

页码：817 / 820

页数：4

共 7 条

[1] Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock [J].

Dellinger, RP ;

Carlet, JM ;

Masur, H ;

Gerlach, H ;

Calandra, T ;

Cohen, J ;

Gea-Banacloche, J ;

Keh, D ;

Marshall, JC ;

Parker, MM ;

Ramsay, G ;

Zimmerman, JL ;

Vincent, JL ;

Levy, MM .

INTENSIVE CARE MEDICINE, 2004, 30 (04) :536-555

[2] Evaluation by Monte Carlo simulation of the pharmacokinetics of two doses of meropenem administered intermittently or as a continuous infusion in healthy volunteers [J].

Krueger, WA ;

Bulitta, J ;

Kinzig-Schippers, M ;

Landersdorfer, C ;

Holzgrabe, U ;

Naber, KG ;

Drusano, GL ;

Sörgel, F .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (05) :1881-1889

[3] Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration [J].

Krueger, WA ;

Neeser, G ;

Schuster, H ;

Schroeder, TH ;

Hoffmann, E ;

Heininger, A ;

Dieterich, HJ ;

Forst, H ;

Unertl, KE .

CHEMOTHERAPY, 2003, 49 (06) :280-286

[4] Pharmacokinetics of meropenem in critically ill patients with acute renal failure treated by continuous hemodiafiltration [J].

Krueger, WA ;

Schroeder, TH ;

Hutchison, M ;

Hoffmann, E ;

Dieterich, HJ ;

Heininger, A ;

Erley, C ;

Wehrle, A ;

Unertl, K .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (09) :2421-2424

[5] The pharmacokinetic and pharmacodynamic profile of tigecycline [J].

Meagher, AK ;

Ambrose, PG ;

Grasela, TH ;

Ellis-Grosse, EJ .

CLINICAL INFECTIOUS DISEASES, 2005, 41 :S333-S340

[6] Continuous infusion of β-lactam antibiotics in severe infections:: a review of its role [J].

Roberts, Jason A. ;

Paratz, Jennifer ;

Paratz, Elizabeth ;

Krueger, Wolfgang A. ;

Lipman, Jeffrey .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (01) :11-18

[7] Correlation between candiduria and departmental antibiotic use [J].

Weinberger, M ;

Sweet, S ;

Leibovici, L ;

Pitlik, SD ;

Samra, Z .

JOURNAL OF HOSPITAL INFECTION, 2003, 53 (03) :183-186

← 1 →